These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9868951)

  • 1. Mechanism of increased serum cytokeratin 19 fragment levels in patients with diabetic nephropathy as a model of chronic renal failure.
    Kashiwabara K; Kishi K; Nakamura H; Yagyu H; Kobayashi K; Watanabe O; Matsuoka T
    Intern Med; 1998 Nov; 37(11):917-21. PubMed ID: 9868951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients.
    Żyłka A; Dumnicka P; Kuśnierz-Cabala B; Gala-Błądzińska A; Ceranowicz P; Kucharz J; Ząbek-Adamska A; Maziarz B; Drożdż R; Kuźniewski M
    Mediators Inflamm; 2018; 2018():7659243. PubMed ID: 30158836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic significance of urinary immunoglobulin G in diabetic nephropathy].
    Yashima I; Hirayama T; Shiiki H; Kanauchi M; Dohi K
    Nihon Jinzo Gakkai Shi; 1999 Dec; 41(8):787-96. PubMed ID: 10655727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between serum cytokeratin 19 fragment and tissue polypeptide antigen levels in patients with non-malignant diseases.
    Kashiwabara K; Nakamura H; Kiguchi T; Matsuoka T
    Clin Chim Acta; 1998 May; 273(1):35-42. PubMed ID: 9620468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum and urinary levels of insulin-like growth factor I in patients with chronic renal disease and diabetes mellitus: its clinical implication.
    Fujihara M; Uemasu J; Kawasaki H
    Clin Nephrol; 1996 Jun; 45(6):372-8. PubMed ID: 8793228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYFRA 21-1 and ProGRP, tumor markers of lung cancer, are elevated in chronic renal failure patients.
    Nakahama H; Tanaka Y; Fujita Y; Fujii M; Sugita M
    Respirology; 1998 Sep; 3(3):207-10. PubMed ID: 9767622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma adrenomedullin levels in patients with non-insulin dependent diabetes mellitus: close relationships with diabetic complications.
    Nakamura T; Honda K; Ishikawa S; Kitamura K; Eto T; Saito T
    Endocr J; 1998 Apr; 45(2):241-6. PubMed ID: 9700478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokeratin-19 fragment in the diagnosis of bladder carcinoma.
    Guo XG; Long JJ
    Tumour Biol; 2016 Oct; 37(10):14329-14330. PubMed ID: 27448817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYFRA 21-1 as a tumor marker used in measuring the serum fragment of cytokeratin subunit 19 by immunoradiometric assay.
    Sarwar M; Tomiyoshi K; Inoue T; Fukazawa K; Endo K
    Ann Nucl Med; 1994 Nov; 8(4):301-6. PubMed ID: 7535552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary copper excretion in type 2 diabetic patients with nephropathy.
    Ito S; Fujita H; Narita T; Yaginuma T; Kawarada Y; Kawagoe M; Sugiyama T
    Nephron; 2001 Aug; 88(4):307-12. PubMed ID: 11474224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy.
    Shimoike T; Inoguchi T; Umeda F; Nawata H; Kawano K; Ochi H
    Metabolism; 2000 Aug; 49(8):1030-5. PubMed ID: 10954022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of five tumor markers for lung cancer in patients with chronic renal failure.
    Nomura F; Koyama A; Ishijima M; Takano S; Narita M; Nakai T
    Oncol Rep; 1998; 5(2):389-92. PubMed ID: 9468564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin.
    Wu C; Wang Q; Lv C; Qin N; Lei S; Yuan Q; Wang G
    Diabetes Res Clin Pract; 2014 Nov; 106(2):343-50. PubMed ID: 25263500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diurnal changes in urinary excretion of IgG, transferrin, and ceruloplasmin depend on diurnal changes in systemic blood pressure in normotensive, normoalbuminuric type 2 diabetic patients.
    Hosoba M; Fujita H; Miura T; Morii T; Shimotomai T; Koshimura J; Yamada Y; Ito S; Narita T
    Horm Metab Res; 2009 Dec; 41(12):910-5. PubMed ID: 19670106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokeratin-19 fragment (CYFRA 21-1) in bladder cancer.
    Morita T; Kikuchi T; Hashimoto S; Kobayashi Y; Tokue A
    Eur Urol; 1997; 32(2):237-44. PubMed ID: 9286660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
    Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F
    Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New electrochemiluminescent immunoassay for the determination of CYFRA 21-1: analytical evaluation and clinical diagnostic performance in urine samples of patients with bladder cancer.
    Sánchez-Carbayo M; Espasa A; Chinchilla V; Herrero E; Megías J; Mira A; Soria F
    Clin Chem; 1999 Nov; 45(11):1944-53. PubMed ID: 10545064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
    Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S
    Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevation of urinary betaig-h3, transforming growth factor-beta-induced protein in patients with type 2 diabetes and nephropathy.
    Ha SW; Kim HJ; Bae JS; Jeong GH; Chung SC; Kim JG; Park SH; Kim YL; Kam S; Kim IS; Kim BW
    Diabetes Res Clin Pract; 2004 Aug; 65(2):167-73. PubMed ID: 15223229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress markers in type 2 diabetes patients with diabetic nephropathy.
    Chou ST; Tseng ST
    Clin Exp Nephrol; 2017 Apr; 21(2):283-292. PubMed ID: 27233502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.